Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“Such a pleasure and honor to co‑chair the clinical trials symposium on Advances in Precision Oncology at American Association for Cancer Research Annual meeting – Plenary Hall H with Jia Jenny Liu from Australia at AACR26.
An amazing session packed with the latest and greatest in precision oncology ALK, ROS1, HER2, EGFR, KRAS, PSMA, FR‑α and more.
If you missed it, catch the virtual replay on AACR Meetings online.
Thanks to the AACR26 meeting organizers and conference chairs for the invite and amazing session and terrific meeting planning”
Other articles featuring Vivek Subbiah and Jia Jenny Liu on OncoDaily.
